This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other leukaemias of specified cell type
C3_OTHER_LEUKAEMIA_SPECIFIED
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
121 |
4. Check minimum number of eventsNone |
121 |
5. Include endpointsNone |
121 |
6. Filter based on genotype QC (FinnGen only) |
87 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Aliae leuc(h)aemiae typo cellulari specificato
Similar endpoints
↥List of similar endpoints to
Other leukaemias of specified cell type
based on the number of shared cases.
Similar with more cases:
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 87 | 49 | 38 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 55.66 | 52.99 | 59.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 93
- Matched controls
- 930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
35.4
61.0
45
24
127
Kela drug reimbursment
Transplant complication
115.3
34.9
36
5
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
17.4
32.5
31
26
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.4
28.2
32
35
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
26.3
24
*
XW000
NOMESCO Finland
Bone marrow biopsy
35.6
25.8
33
14
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
24.0
22
*
L04AA06
ATC
mycophenolic acid; systemic
41.9
20.5
25
8
ZX120
NOMESCO Finland
Intravenous
8.7
20.1
32
53
L04AA01
ATC
[U] ciclosporin
66.8
18.9
21
*
L04AD01
ATC
ciclosporin; systemic
35.4
17.5
22
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.5
16.5
36
82
WW500
NOMESCO Finland
Blood transfusion
15.0
14.3
24
21
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
27.4
13.5
18
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.4
13.2
35
93
L04AD02
ATC
tacrolimus; systemic
81.3
13.0
14
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
81.3
13.0
14
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
44.1
12.6
15
*
Z94.0
ICD-10 Finland
Kidney transplant status
44.1
12.6
15
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
44.1
12.6
15
*
R50.9
ICD-10 Finland
Fever, unspecified
4.9
11.8
36
107
C94.4
ICD-10 Finland
Acute panmyelosis with myelofibrosis
+∞
11.7
11
*
C03CA01
ATC
furosemide; systemic
4.5
11.7
51
199
TK800
NOMESCO Finland
Hemodialysis
23.8
11.6
16
8
J01MA12
ATC
levofloxacin; systemic
4.8
11.6
35
103
Z3226
NOMESCO Finland
Physiotherapist
4.7
11.4
37
115
Z49.1
ICD-10 Finland
Extracorporeal dialysis
68.0
10.9
12
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
68.0
10.9
12
*
C94.1
ICD-10 Finland
Chronic erythremia
+∞
10.6
10
*
Z3231
NOMESCO Finland
Registered nurse
4.2
10.6
48
190
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.6
10.5
67
336
M04AA01
ATC
allopurinol; systemic
5.2
10.3
26
65
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.0
10.3
27
70
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
23.2
10.2
14
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
10.1
26
66
H02AB09
ATC
hydrocortisone; systemic
13.6
10.1
17
15
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
61.6
9.9
11
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
61.6
9.9
11
*
J01MA14
ATC
moxifloxacin; systemic
5.9
9.8
20
41
B03XA01
ATC
erythropoietin; parenteral
110.8
9.6
10
*
C94.2
ICD-10 Finland
Acute megakaryoblastic leukaemia
+∞
9.5
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.5
9.4
21
47
Z2221
NOMESCO Finland
Medical doctor
3.9
9.3
43
169
Z2446
NOMESCO Finland
Social worker
5.7
9.3
20
43
R4110
NOMESCO Finland
Physiotherapy
3.8
9.3
44
176
H02AB04
ATC
methylprednisolone; systemic
4.4
9.3
29
86
ZX108
NOMESCO Finland
Inhalation
41.1
9.2
11
*
A12AA04
ATC
calcium carbonate; oral
41.1
9.2
11
*
A11CC03
ATC
alfacalcidol; systemic
21.3
9.2
13
7
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
9.3
9.2
19
25
L03AA02
ATC
filgrastim; parenteral
11.8
8.9
16
16
N18.0
ICD-10 Finland
End-stage renal disease
55.4
8.9
10
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
55.4
8.9
10
*
TGC00
NOMESCO Finland
Bronchial lavation
18.6
8.8
13
8
L01BB02
ATC
mercaptopurine; oral
30.8
8.7
11
*
Z94.1
ICD-10 Finland
Heart transplant status
+∞
8.5
8
*
6BA02, ,
NOMESCO Finland
+∞
8.5
8
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
8.5
8
*
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
8.5
8
*
L04AX01
ATC
azathioprine; systemic
10.5
8.4
16
18
A05AA02
ATC
ursodeoxycholic acid; oral
19.4
8.3
12
7
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
36.9
8.3
10
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
7.7
8.3
19
30
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.9
8.2
16
19
Z3229
NOMESCO Finland
Other healthcare associate professional
5.2
8.1
19
44
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.3
7.9
15
17
D07AB08
ATC
desonide; topical
4.8
7.8
20
50
N18.8
ICD-10 Finland
Other chronic renal failure
20.5
7.8
11
6
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
86.7
7.5
8
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
86.7
7.5
8
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.3
7.5
46
212
J02AC03
ATC
voriconazole; systemic
+∞
7.4
7
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.2
7.4
16
23
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
8.7
7.2
15
20
TAB00
NOMESCO Finland
Lumbar puncture
7.8
7.2
16
24
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.8
7.2
16
24
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
43.3
6.9
8
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
24.6
6.8
9
*
137
Kela drug reimbursment
Uraemia requiring dialysis
24.6
6.8
9
*
B03XA02
ATC
darbepoetin alfa; parenteral
13.6
6.8
11
9
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.3
6.8
12
12
ZXD05
NOMESCO Finland
Urgent procedure
3.2
6.7
39
172
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
74.8
6.5
7
*
Z94.4
ICD-10 Finland
Liver transplant status
74.8
6.5
7
*
B07.9
ICD-10 Finland
Verruca simplex
10.4
6.5
12
13
J05AB01
ATC
aciclovir; systemic
3.3
6.5
33
134
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.5
6.4
28
103
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
6.4
33
135
20700
ICD-8 Finland
Other and unspecified leukaemia, Leukaemia, acute
+∞
6.3
6
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
6.3
6
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
6.3
6
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
6.3
6
*
ZXA00
NOMESCO Finland
Right side
3.1
6.2
36
157
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.2
6.2
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
41
106
6.13
16.40
2.1
1.6
—
—
—
0
0
29
56
7.07
15.56
3.3
1.7
—
—
—
0
0
39
102
5.86
15.27
2.2
1.6
—
—
—
0
0
46
143
5.39
14.68
3.7
1.8
—
—
—
0
0
45
149
4.91
13.04
11.8
3.8
0.79
0.82
mmol/l
0.76
45
139
21
19
13.90
12.31
1.5
1.2
—
—
—
0
0
23
53
5.44
10.00
2.0
1.5
—
—
—
0
0
73
416
4.51
8.99
28.2
7.9
1.21
1.21
mmol/l
0.27
68
365
20
32
7.66
8.61
3.9
2.5
89.70
88.22
%
0.07
20
32
36
132
3.82
8.54
6.0
2.4
2.10
2.32
g/l
1.02
36
123
33
117
3.82
8.18
6.6
2.5
27.22
23.94
%
0.47
33
112
18
28
7.70
7.89
2.3
1.3
—
—
—
0
0
35
137
3.49
7.39
6.3
2.5
12.67
14.27
umol/l
0.65
35
131
10
5
22.11
7.30
4.0
1.2
—
—
—
0
0
16
26
7.20
6.83
4.6
2.7
206.44
202.62
%
0.06
16
26
15
23
7.55
6.66
5.5
1.5
—
—
—
0
0
75
490
3.74
6.38
32.0
10.3
3.80
4.07
e9/l
0.35
70
422
29
113
3.28
6.03
11.6
7.9
104.59
104.33
mmol/l
0.11
29
113
10
9
12.26
5.95
6.1
1.9
—
—
—
0
0
10
9
12.26
5.95
6.1
1.9
—
—
—
0
0
10
9
12.26
5.95
6.1
1.9
—
—
—
0
0
43
214
2.88
5.80
6.2
2.6
—
—
—
0
0
16
33
5.63
5.76
5.4
1.6
—
—
—
0
0
9
7
14.04
5.71
10.1
3.6
1.11
1.14
%
—
9
7
14
25
6.39
5.64
2.3
2.4
—
—
—
0
0
16
34
5.46
5.63
6.1
1.6
—
—
—
0
0
35
161
2.88
5.39
4.6
2.9
0.89
0.81
e6/l
0.07
22
90
5
0
+∞
5.25
1.6
0.0
—
—
—
0
0
24
90
3.25
5.25
9.5
3.6
5.31
4.82
kpa
0.48
24
90
14
29
5.49
5.06
3.1
2.6
—
—
—
0
0
26
105
3.05
5.01
10.4
4.6
5.51
5.62
kpa
0.20
26
105
53
311
2.64
4.98
8.1
3.5
—
—
—
0
0
9
10
9.81
4.90
1.9
1.9
3.18
3.97
mg/l
—
9
10
62
397
2.69
4.81
8.5
3.0
—
—
estimate
—
0
0
32
149
2.75
4.74
5.6
3.0
1.43
1.99
e6/l
0.22
18
78
21
78
3.19
4.63
5.2
4.1
—
—
—
0
0
46
259
2.54
4.62
6.0
3.3
0.19
0.41
e6/l
0.92
39
181
18
62
3.36
4.46
8.3
3.8
1.49
1.53
mmol/l
0.02
13
44
7
6
12.47
4.35
3.6
2.7
—
—
—
0
0
9
13
7.53
4.27
6.1
1.5
—
—
—
0
0
10
17
6.45
4.26
2.8
1.4
—
—
—
0
0
7
7
10.68
4.08
3.1
1.1
—
—
—
0
0
18
66
3.14
4.03
9.7
3.5
23.29
23.75
mmol/l
0.21
18
66
9
15
6.51
3.92
6.2
1.4
—
—
—
0
0
6
5
12.69
3.81
1.2
1.0
—
—
—
0
0
65
456
2.41
3.71
26.9
7.2
11.72
11.63
umol/l
0.02
65
432
15
52
3.25
3.66
10.6
10.7
0.60
0.59
%
0.02
15
52
11
26
4.65
3.64
2.8
1.6
—
—
—
0
0
15
53
3.18
3.55
10.6
10.5
1.36
1.42
%
0.06
15
53
18
71
2.90
3.55
6.1
3.8
51.40
67.28
ml/min/173m2
—
5
32
6
6
10.57
3.55
2.5
1.5
—
—
—
0
0
7
10
7.46
3.43
2.0
1.2
—
—
—
0
0
7
10
7.46
3.43
1.1
1.1
—
—
—
0
0
10
23
4.74
3.42
2.3
1.4
—
—
—
0
0
9
19
5.12
3.33
2.9
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
29
4.16
3.31
4.4
3.2
0.28
0.40
iu/ml
—
5
20
9
21
4.63
3.08
2.7
1.7
—
—
—
0
0
12
37
3.57
3.07
2.5
1.4
—
—
—
0
0
42
264
2.08
2.94
6.4
4.1
30.54
9.45
mg/mmol
0.98
30
167
5
6
8.71
2.78
4.6
1.3
77.60
111.67
%
—
5
6
5
6
8.71
2.78
1.2
1.0
—
—
—
0
0
8
19
4.50
2.74
1.4
1.2
278.09
22.57
u/l
—
8
14
8
19
4.50
2.74
3.5
1.6
—
—
—
0
0
6
10
6.32
2.74
1.2
1.2
—
—
—
0
0
42
271
2.00
2.68
7.2
3.4
2.31
2.36
mmol/l
1.08
42
245
9
26
3.72
2.56
1.2
1.3
—
—
—
0
0
8
21
4.06
2.52
1.3
1.3
—
—
—
0
0
8
21
4.06
2.52
1.3
1.3
—
—
—
0
0
7
17
4.36
2.41
2.7
1.6
—
—
—
0
0
49
347
1.87
2.28
2.0
2.1
86.56
95.77
pmol/l
0.68
29
170
59
444
1.90
2.26
7.2
3.8
0.00
0.00
estimate
-0.00
14
90
59
446
1.88
2.21
7.2
3.8
0.00
0.00
estimate
-0.00
14
91
7
19
3.89
2.19
8.4
1.2
64.29
374.54
e6/l
—
7
13
7
19
3.89
2.19
8.4
1.1
55.00
2.31
e6/l
—
7
13
8
25
3.40
2.15
2.0
1.3
0.88
0.92
g/l
—
8
25
59
449
1.86
2.13
7.3
3.9
0.00
0.00
estimate
-0.00
14
85
5
10
5.21
2.10
4.2
1.9
—
—
—
0
0
5
10
5.21
2.10
4.2
1.9
—
—
—
0
0
5
10
5.21
2.10
4.2
1.9
—
—
—
0
0
5
10
5.21
2.10
4.2
1.9
—
—
—
0
0
7
21
3.52
2.01
1.9
1.5
—
—
—
0
0
5
11
4.73
1.96
4.2
1.8
—
—
—
0
0
5
11
4.73
1.96
4.2
1.8
—
—
—
0
0
76
636
2.07
1.96
30.1
8.5
93.24
85.26
u/l
0.51
76
600
6
17
3.70
1.87
1.7
1.2
—
—
—
0
0
5
12
4.34
1.84
2.2
2.1
0.15
0.47
nmol/l
—
5
7
8
32
2.64
1.64
9.3
2.1
—
—
—
0
0
14
72
2.11
1.59
11.6
7.7
23.66
25.22
mmol/l
0.81
14
72
35
245
1.69
1.56
8.3
3.9
0.00
0.00
estimate
—
7
81
8
35
2.40
1.30
7.5
3.5
28.75
1225.44
u/ml
—
8
27
5
19
2.72
1.23
6.4
1.5
3.84
7.82
u/ml
—
5
19
11
57
2.05
1.23
21.8
5.1
1.23
1.22
mmol/l
0.20
11
49
7
30
2.44
1.15
3.9
2.0
—
—
—
0
0
42
328
1.51
1.12
7.6
3.7
0.14
0.00
estimate
0.47
14
75
10
53
1.99
1.06
1.8
2.8
276.20
278.94
ng/l
—
10
47
0
30
0.00
0.99
0.0
1.1
—
1.67
—
0
21
6
32
1.93
0.83
2.3
1.2
—
—
—
0
0
6
32
1.93
0.83
2.3
1.2
—
—
—
0
0
6
34
1.82
0.77
1.2
1.5
38.17
42.11
u/l
—
6
28
58
507
1.38
0.75
3.0
3.3
—
—
—
0
0
5
26
1.97
0.72
1.6
1.5
—
—
—
0
0
5
26
1.97
0.72
3.4
1.5
59.00
38.15
nmol/l
—
5
26
25
192
1.41
0.69
9.9
3.7
1.01
1.02
kg/l
2.05
19
126
29
239
1.31
0.51
6.9
3.3
2.09
0.00
estimate
0.56
11
70
7
103
0.65
0.42
1.7
2.0
—
—
—
0
0
80
831
0.73
0.38
38.5
12.4
26.79
25.95
u/l
0.18
80
815
18
217
0.79
0.34
1.1
1.5
1.60
0.99
u/ml
—
5
56
6
46
1.32
0.34
1.8
1.8
—
—
—
0
0
18
215
0.80
0.31
3.1
4.2
33.39
22.24
%
—
8
110
72
748
0.83
0.24
6.6
5.0
5.81
5.92
mmol/l
0.36
66
692
7
95
0.72
0.23
1.6
1.8
—
—
—
0
0
11
89
1.27
0.22
17.0
6.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
1.60
—
0
5
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
6.8
—
121.00
—
0
10
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
6
47
1.30
0.21
2.3
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
15.91
—
0
13
72
744
0.86
0.19
5.8
5.4
2.19
1.85
mu/l
1.12
67
686
35
327
1.11
0.14
7.6
3.6
39.64
37.64
ng/l
0.05
29
227
10
115
0.85
0.11
1.8
1.5
—
—
—
0
0
7
63
1.12
0.08
2.1
1.3
—
—
—
0
0
13
143
0.89
0.08
1.2
1.3
4.10
7.04
u/ml
—
7
53
14
153
0.90
0.08
1.1
1.3
16.30
38.38
iu/ml
—
7
54
17
164
1.04
0.00
1.5
1.7
—
—
—
0
0
54
536
1.02
0.00
7.7
3.4
54.87
51.96
u/l
0.13
54
508
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
13.25
—
0
8
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
61.29
—
0
8
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
4.67
—
0
6
0
7
0.00
-0.00
0.0
1.6
—
3.14
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OTHER_LEUKAEMIA_SPECIFIED – Other leukaemias of specified cell type
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).